7729.TWO
Price:
$42.35
Market Cap:
$2.82B
Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include stemchymal, stemchymal therapeutic advantages and stemchymal application fields. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2024-03-11
Stock Exchange
TWO
Ticker
7729.TWO
According to Steminent Biotherapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.33. This represents a change of -34.08% compared to the average of 9.60 of the last 4 quarters.
The mean historical Current Ratio of Steminent Biotherapeutics Inc. over the last ten years is 7.97. The current 6.33 Current Ratio has changed 7.83% with respect to the historical average. Over the past ten years (40 quarters), 7729.TWO's Current Ratio was at its highest in in the June 2023 quarter at 14.27. The Current Ratio was at its lowest in in the June 2025 quarter at 6.33.
Average
7.97
Median
7.43
Minimum
2.90
Maximum
12.07
Discovering the peaks and valleys of Steminent Biotherapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 271.95%
Maximum Annual Current Ratio = 12.07
Minimum Annual Increase = -38.41%
Minimum Annual Current Ratio = 2.90
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 7.43 | -38.41% |
| 2023 | 12.07 | 80.56% |
| 2022 | 6.68 | -38.09% |
| 2021 | 10.79 | 271.95% |
The current Current Ratio of Steminent Biotherapeutics Inc. (7729.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.73
5-year avg
7.97
10-year avg
7.97
Steminent Biotherapeutics Inc.’s Current Ratio is less than TaiRx, Inc. (20.60), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (3.10), greater than GlycoNex Incorporation (1.67), greater than Intech Biopharm Corporation (1.71), less than Taiwan Bio Therapeutics Co., Ltd (8.15), less than Anti-Microbial Savior BioteQ Co., Ltd (18.78), less than HeXun Biosciences Co., Ltd. (8.26), less than Hcmed (11.14), less than Sinew Pharma Inc. (53.40), greater than Sunny Pharmtech Inc. (1.30),
| Company | Current Ratio | Market cap |
|---|---|---|
| 20.60 | $2.54B | |
| 3.10 | $2.70B | |
| 1.67 | $2.33B | |
| 1.71 | $2.46B | |
| 8.15 | $2.29B | |
| 18.78 | $2.62B | |
| 8.26 | $2.56B | |
| 11.14 | $2.29B | |
| 53.40 | $2.77B | |
| 1.30 | $2.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Steminent Biotherapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Steminent Biotherapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Steminent Biotherapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the highest Current Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 3-year average Current Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 5-year average Current Ratio for Steminent Biotherapeutics Inc. (7729.TWO)?
How does the current Current Ratio for Steminent Biotherapeutics Inc. (7729.TWO) compare to its historical average?